E-LIB Suche - Ergebnisse für: Deleuran, Mette

1

Targeted Combined Endpoint Improvement in Patient and Disea..:

Kwatra, Shawn G. ; De Bruin-Weller, Marjolein ; Silverberg, Jonathan I....
Acta Dermato-Venereologica. 104 (2024) - p. adv18452 , 2024

Link: https://doi.org/10.2340/..

2

Long-Term Efficacy Of Dupilumab In Adults With Moderate-to-..:

Beck, Lisa ; Bissonnette, Robert ; Deleuran, Mette...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB5 , 2024

Link: https://doi.org/10.1016/..

3

Early and Sustained Improvements in Symptoms and Quality of..:

Silverberg, Jonathan I. ; Gooderham, Melinda J. ; Paller, Amy S....
American Journal of Clinical Dermatology. 25 (2024) 3 - p. 485-496 , 2024

Link: https://doi.org/10.1007/..

4

The doctors' perception of skin diseases in general practic..:

Sofie Froelunde, Anne ; Deleuran, Mette ; Thomsen, Janus L..
JEADV Clinical Practice. , 2024

Link: https://doi.org/10.1002/..

5

Treatment and referral patterns of patients with atopic der..:

Danielsen, Anna Kathrine ; Frølunde, Anne Sofie ; Heilskov, Sofine...
JEADV Clinical Practice. , 2024

Link: https://doi.org/10.1002/..

6

530 - Treatment efficacy in patients with moderate-to-sever..:

Gooderham, Melinda J ; Weidinger, Stephan ; Simpson, Eric L...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii32-ii33 , 2024

Link: https://doi.org/10.1093/..

7

Abrocitinib in the Treatment of Moderate-to-Severe Atopic D..:

Shi, Vivian ; Bhutani, Tina ; Deleuran, Mette...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s153 , 2023

Link: https://doi.org/10.25251..

8

A nationwide 104 weeks real‐world study of dupilumab in adu..:

Vittrup, Ida ; Krogh, Niels Steen ; Larsen, Henrik Hedegaard Pliess...
Journal of the European Academy of Dermatology and Venereology. 37 (2023) 5 - p. 1046-1055 , 2023

Link: https://doi.org/10.1111/..

9

The Treat-to-Target Project in Atopic Dermatitis: One Year ..:

De Bruin-Weller, Marjolein ; Deleuran, Mette ; Biedermann, Tilo...
Acta Dermato-Venereologica. 103 (2023) - p. adv5382 , 2023

Link: https://doi.org/10.2340/..

10

3 years of tralokinumab treatment provides long term diseas..:

Warren, Richard ; Reich, Kristian ; Simpson, Eric...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s142 , 2023

Link: https://doi.org/10.25251..

11

44095 Response to Abrocitinib up to Week 96 According to Sh..:

Silverberg, Jonathan I. ; Reich, Kristian ; de Bruin-Weller, Marjolein...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB218 , 2023

Link: https://doi.org/10.1016/..

12

42262 Sustained Improvement Over 52 Weeks in Patient-Report..:

Silverberg, Jonathan I. ; Deleuran, Mette ; Gold, Linda S....
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB90 , 2023

Link: https://doi.org/10.1016/..

13

Interpreting the Relationship Among Itch, Sleep, and Work P..:

Yosipovitch, Gil ; Gooderham, Melinda J. ; Ständer, Sonja...
American Journal of Clinical Dermatology. 25 (2023) 1 - p. 127-138 , 2023

Link: https://doi.org/10.1007/..

14

Dupilumab Treatment Reduces Total IgE Levels in Patients 6 ..:

Siegfried, Elaine ; Cork, Michael ; Boguniewicz, Mark...
Journal of Allergy and Clinical Immunology. 151 (2023) 2 - p. AB149 , 2023

Link: https://doi.org/10.1016/..

15

Dupilumab improves patient-reported symptoms and health-rel..:

Flohr, Carsten ; Irvine, Alan D ; Cork, Michael J...
British Journal of Dermatology. 189 (2023) 2 - p. 238-240 , 2023

Link: https://doi.org/10.1093/..